Society of surgical oncology fellowship training: Where we have been, where we are now, and where we are going
โ Scribed by Russell S. Berman; Scott H. Kurtzman; Mitchell C. Posner; Jeffrey E. Gershenwald
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 55 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Maternal pregestational diabetes (type 1 or type 2) poses an increased risk for a broad spectrum of birth defects. To our knowledge, this problem first came to the attention of the Teratology Society at the 14th Annual Meeting in Vancouver, B.C. in 1974, with a presentation by Lewis Hol
Quality of life, symptom management, and social support are the traditional foci for the practice of psychosocial oncology and clinical research into the behavioral and psychologic aspects of cancer. The current paradigm for research in this area primarily assesses patient responses to cancer relate
The dopamine (DA) D(1) receptor is the most highly expressed DA receptor subtype among the DA receptor family. Although the first DA D(1) receptor selective ligand SCH-23390 (1) was introduced more than two decades ago, clinically useful D(1) receptor selective ligands are rare. A renewed interest w
As we approach the beginning of the twenty-first century, it's important to pause and evaluate where we've been. What has happened to standard setting over the past century? What direction are we going? And what can the past teach us about the future?